The national epidemic of chronic kidney disease - What we know and what we can do

被引:16
作者
Eknoyan, G
Levey, AS
Levin, NW
Keane, WF
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[3] Renal Res Inst, New York, NY USA
[4] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
关键词
D O I
10.3810/pgm.2001.09.1024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The alarming increase in the incidence and mortality rate of end-stage renal disease (ESRD) over the past several years has prompted: concerned physicians to ask why-and to ponder what can he done to ameliorate the situation. This article, the first in a seven-part series coordinated by the National Kidney Foundation, examines the factors surrounding the epidemic of chronic kidney disease and introduces readers to the organization's new clinical practice guidelines developed through its Kidney Disease Outcomes Quality Initiative. These recommendations emphasize early detection and treatment and offer a new avenue of communication between primary care physicians and nephrologists.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 16 条
[1]   Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[2]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[3]   The dialysis outcomes quality initiative: History, impact, and prospects [J].
Eknoyan, G ;
Levin, NW ;
Steinberg, EP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :S69-S75
[4]   An overview of the national kidney foundation-dialysis outcomes quality initiative implementation [J].
Eknoyan, G ;
Levin, NW .
ADVANCES IN RENAL REPLACEMENT THERAPY, 1999, 6 (01) :3-6
[5]   CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGE RENAL-DISEASE THERAPY [J].
FOLEY, RN ;
PARFREY, PS ;
HARNETT, JD ;
KENT, GM ;
MARTIN, CJ ;
MURRAY, DC ;
BARRE, PE .
KIDNEY INTERNATIONAL, 1995, 47 (01) :186-192
[6]   Proteinuria: Its clinical importance and role in progressive renal disease [J].
Keane, WF .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :S97-S105
[7]   Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the national kidney foundation [J].
Keane, WF ;
Eknoyan, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (05) :1004-1010
[8]   Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? [J].
Levey, AS ;
Beto, JA ;
Coronado, BE ;
Eknoyan, G ;
Foley, RN ;
Kasiske, BL ;
Klag, MJ ;
Mailloux, LU ;
Manske, CL ;
Meyer, KB ;
Parfrey, PS ;
Pfeffer, MA ;
Wenger, NK ;
Wilson, PWF ;
Wright, JT .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :853-906
[9]  
LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159
[10]   Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention [J].
Levin, A ;
Singer, J ;
Thompson, CR ;
Ross, H ;
Lewis, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :347-354